Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets
Sarcomas are rare tumours with many different subtypes and clinical outcomes; a broader knowledge of their genetic features is required. Here, the authors analyse 2138 soft tissue and bone sarcomas across 45 subtypes using MSK-IMPACT targeted sequencing and find genomic groups that are distinct from...
Similar Items
-
Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center
by: Martina Bradic, et al.
Published: (2022-04-01) -
Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma
by: Sandra P. D’Angelo, et al.
Published: (2022-06-01) -
343 Defining and therapeutically targeting a fusion-derived public neoantigen in desmoplastic small round cell tumor using T-cell receptor gene therapy
by: Christopher A Klebanoff, et al.
Published: (2023-11-01) -
Preface "Landslide hazard and risk assessment at different scales"
by: P. Reichenbach, et al.
Published: (2013-09-01) -
Immunotherapeutic Targeting of GPC3 in Pediatric Solid Embryonal Tumors
by: Michael V. Ortiz, et al.
Published: (2019-02-01)